Ms. Jennifer Larson's most recent trade in Bicara Therapeutics Inc. was a trade of 285,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc | Ms. Jennifer Larson | Chief Financial Officer | 12 Aug 2026 | 285,000 | 285,000 | - | - | Stock Option (Right to Buy) |